US Stock MarketDetailed Quotes

SYRS Syros Pharmaceuticals

Watchlist

1.6400
-0.0200-1.20%

Close Aug 30 16:00 ET

1.6400
0.00000.00%

Post 20:01 ET

43.97MMarket Cap-377P/E (TTM)

Syros Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-32.52%-29.67M

15.73%-31.1M

10.85%-109.71M

40.28%-18.56M

10.98%-31.86M

14.49%-22.39M

-22.93%-36.9M

-23.63%-123.07M

-35.33%-31.08M

-27.23%-35.79M

Net income from continuing operations

35.66%-23.33M

84.41%-3.71M

-73.87%-164.57M

-1,248.64%-64.38M

-32.69%-40.14M

-5.15%-36.26M

5.40%-23.79M

-9.35%-94.65M

79.95%-4.77M

-16.24%-30.25M

Operating gains losses

-244.35%-4.48M

-204.60%-27M

197.56%37.28M

220.95%37.2M

220.45%5.84M

2,090.38%3.11M

-262.13%-8.87M

-129.03%-38.21M

-1,099.06%-30.76M

-163.94%-4.85M

Depreciation and amortization

-49.08%331K

-47.65%334K

-16.78%2.25M

-50.07%352K

-7.13%612K

-1.66%650K

-6.31%638K

-10.34%2.71M

-8.80%705K

-13.86%659K

Other non cash items

-18.79%121K

-24.38%152K

-31.79%650K

-23.50%153K

-39.75%147K

-42.25%149K

-19.92%201K

34.99%953K

8.11%200K

35.56%244K

Change In working capital

-150.35%-3.92M

60.24%-2.86M

191.63%5.06M

953.37%6.26M

61.12%-1.79M

62.77%7.79M

-14.46%-7.2M

47.96%-5.52M

212.93%594K

-35.13%-4.6M

-Change in receivables

--0

31.83%1.69M

2,062.34%1.67M

-82.57%91K

-98.99%9K

65.02%-71K

298.30%1.29M

-88.21%77K

135.88%522K

-Change in prepaid assets

-152.33%-2.06M

18.06%1.56M

169.11%1.94M

210.14%1.48M

97.08%-39K

-144.31%-816K

549.26%1.32M

-182.11%-2.81M

-263.94%-1.34M

35.00%-1.34M

-Change in payables and accrued expense

-122.59%-1.69M

46.41%-4.2M

-42.20%2.95M

181.53%2.99M

119.19%323K

-17.60%7.48M

-134.45%-7.83M

4.78%5.11M

-69.65%1.06M

-174.83%-1.68M

-Change in other current assets

-96.28%90K

-94.01%42K

256.04%3.76M

130.99%521K

78.46%116K

633.77%2.42M

307.40%701K

-101.25%-2.41M

-234.86%-1.68M

103.13%65K

-Change in other current liabilities

----

-12.82%-264K

-13.09%-959K

-11.89%-254K

----

-13.04%-234K

---848K

---227K

---207K

-Change in other working capital

----

26.00%-4.33M

-105.14%-139K

19.84%-1.58M

63.41%-1.53M

54.94%-1.09M

53.71%-5.85M

154.20%2.71M

9.78%-1.97M

Cash from discontinued investing activities

Operating cash flow

-32.52%-29.67M

15.73%-31.1M

10.85%-109.71M

40.28%-18.56M

10.98%-31.86M

14.49%-22.39M

-22.93%-36.9M

-23.63%-123.07M

-35.33%-31.08M

-27.23%-35.79M

Investing cash flow

Cash flow from continuing investing activities

-23.86%25.07M

4.30%-24.64M

-44.43%37.34M

-95.97%1.52M

362.53%28.64M

107.21%32.92M

-448.75%-25.75M

227.60%67.19M

15,496.33%37.72M

135.79%6.19M

Net PPE purchase and sale

-3,000.00%-29K

112.34%29K

203.79%1.29M

325.82%1.52M

--0

100.90%1K

-83.59%-235K

0.32%-1.24M

-175.10%-674K

-5.81%-328K

Net investment purchase and sale

-24.15%24.97M

3.31%-24.67M

-47.32%36.05M

--0

339.26%28.64M

105.76%32.92M

-439.68%-25.51M

233.10%68.43M

--38.4M

138.37%6.52M

Cash from discontinued investing activities

Investing cash flow

-23.86%25.07M

4.30%-24.64M

-44.43%37.34M

-95.97%1.52M

362.53%28.64M

107.21%32.92M

-448.75%-25.75M

227.60%67.19M

15,496.33%37.72M

135.79%6.19M

Financing cash flow

Cash flow from continuing financing activities

-70.71%41K

-400.00%-265K

-66.83%43.46M

505.31%43.38M

-100.00%-5K

162.78%140K

43.01%-53K

85.85%131.05M

-11,248.96%-10.7M

212,135.82%142.06M

Net issuance payments of debt

--0

77.66%-65K

96.00%-3K

93.24%-5K

94.44%-4K

24.29%-53K

-9.81%-291K

-8.70%-75K

-10.45%-74K

Net common stock issuance

----

-63.85%43.27M

620.82%43.27M

----

70.15%119.68M

---8.31M

----

Proceeds from stock option exercised by employees

----

17.89%257K

4.63%113K

--0

----

-54.58%218K

-36.47%108K

--1K

Net other financing activities

---74K

---265K

----

27,997.56%11.44M

-48,460.00%-2.43M

--14.15M

Cash from discontinued financing activities

Financing cash flow

-70.71%41K

-400.00%-265K

-66.83%43.46M

505.31%43.38M

-100.00%-5K

162.78%140K

43.01%-53K

85.85%131.05M

-11,248.96%-10.7M

212,135.82%142.06M

Net cash flow

Beginning cash position

-20.59%85.64M

-16.95%141.65M

78.80%170.55M

-33.97%115.31M

90.71%118.53M

48.43%107.85M

78.80%170.55M

-46.13%95.39M

47.35%174.62M

-62.10%62.15M

Current changes in cash

-142.70%-4.56M

10.68%-56M

-138.46%-28.91M

747.97%26.34M

-102.87%-3.22M

201.58%10.68M

-175.89%-62.7M

192.02%75.17M

82.42%-4.07M

347.21%112.47M

End cash Position

-31.59%81.08M

-20.59%85.64M

-16.95%141.65M

-33.97%115.31M

90.71%118.53M

48.43%107.85M

78.80%170.55M

47.35%174.62M

Free cash flow

-32.53%-29.67M

16.26%-31.1M

11.53%-109.98M

41.43%-18.6M

11.79%-31.86M

14.85%-22.39M

-23.19%-37.14M

-23.34%-124.31M

-36.80%-31.76M

-27.00%-36.12M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-32.52%-29.67M	15.73%-31.1M	10.85%-109.71M	40.28%-18.56M	10.98%-31.86M	14.49%-22.39M	-22.93%-36.9M	-23.63%-123.07M	-35.33%-31.08M	-27.23%-35.79M
Net income from continuing operations	35.66%-23.33M	84.41%-3.71M	-73.87%-164.57M	-1,248.64%-64.38M	-32.69%-40.14M	-5.15%-36.26M	5.40%-23.79M	-9.35%-94.65M	79.95%-4.77M	-16.24%-30.25M
Operating gains losses	-244.35%-4.48M	-204.60%-27M	197.56%37.28M	220.95%37.2M	220.45%5.84M	2,090.38%3.11M	-262.13%-8.87M	-129.03%-38.21M	-1,099.06%-30.76M	-163.94%-4.85M
Depreciation and amortization	-49.08%331K	-47.65%334K	-16.78%2.25M	-50.07%352K	-7.13%612K	-1.66%650K	-6.31%638K	-10.34%2.71M	-8.80%705K	-13.86%659K
Other non cash items	-18.79%121K	-24.38%152K	-31.79%650K	-23.50%153K	-39.75%147K	-42.25%149K	-19.92%201K	34.99%953K	8.11%200K	35.56%244K
Change In working capital	-150.35%-3.92M	60.24%-2.86M	191.63%5.06M	953.37%6.26M	61.12%-1.79M	62.77%7.79M	-14.46%-7.2M	47.96%-5.52M	212.93%594K	-35.13%-4.6M
-Change in receivables	--0	--0	31.83%1.69M	2,062.34%1.67M	-82.57%91K	-98.99%9K	65.02%-71K	298.30%1.29M	-88.21%77K	135.88%522K
-Change in prepaid assets	-152.33%-2.06M	18.06%1.56M	169.11%1.94M	210.14%1.48M	97.08%-39K	-144.31%-816K	549.26%1.32M	-182.11%-2.81M	-263.94%-1.34M	35.00%-1.34M
-Change in payables and accrued expense	-122.59%-1.69M	46.41%-4.2M	-42.20%2.95M	181.53%2.99M	119.19%323K	-17.60%7.48M	-134.45%-7.83M	4.78%5.11M	-69.65%1.06M	-174.83%-1.68M
-Change in other current assets	-96.28%90K	-94.01%42K	256.04%3.76M	130.99%521K	78.46%116K	633.77%2.42M	307.40%701K	-101.25%-2.41M	-234.86%-1.68M	103.13%65K
-Change in other current liabilities	----	-12.82%-264K	-13.09%-959K	-11.89%-254K	----	----	-13.04%-234K	---848K	---227K	---207K
-Change in other working capital	----	----	26.00%-4.33M	-105.14%-139K	19.84%-1.58M	63.41%-1.53M	54.94%-1.09M	53.71%-5.85M	154.20%2.71M	9.78%-1.97M
Cash from discontinued investing activities
Operating cash flow	-32.52%-29.67M	15.73%-31.1M	10.85%-109.71M	40.28%-18.56M	10.98%-31.86M	14.49%-22.39M	-22.93%-36.9M	-23.63%-123.07M	-35.33%-31.08M	-27.23%-35.79M
Investing cash flow
Cash flow from continuing investing activities	-23.86%25.07M	4.30%-24.64M	-44.43%37.34M	-95.97%1.52M	362.53%28.64M	107.21%32.92M	-448.75%-25.75M	227.60%67.19M	15,496.33%37.72M	135.79%6.19M
Net PPE purchase and sale	-3,000.00%-29K	112.34%29K	203.79%1.29M	325.82%1.52M	--0	100.90%1K	-83.59%-235K	0.32%-1.24M	-175.10%-674K	-5.81%-328K
Net investment purchase and sale	-24.15%24.97M	3.31%-24.67M	-47.32%36.05M	--0	339.26%28.64M	105.76%32.92M	-439.68%-25.51M	233.10%68.43M	--38.4M	138.37%6.52M
Cash from discontinued investing activities
Investing cash flow	-23.86%25.07M	4.30%-24.64M	-44.43%37.34M	-95.97%1.52M	362.53%28.64M	107.21%32.92M	-448.75%-25.75M	227.60%67.19M	15,496.33%37.72M	135.79%6.19M
Financing cash flow
Cash flow from continuing financing activities	-70.71%41K	-400.00%-265K	-66.83%43.46M	505.31%43.38M	-100.00%-5K	162.78%140K	43.01%-53K	85.85%131.05M	-11,248.96%-10.7M	212,135.82%142.06M
Net issuance payments of debt	--0	--0	77.66%-65K	96.00%-3K	93.24%-5K	94.44%-4K	24.29%-53K	-9.81%-291K	-8.70%-75K	-10.45%-74K
Net common stock issuance	----	----	-63.85%43.27M	620.82%43.27M	----	----	----	70.15%119.68M	---8.31M	----
Proceeds from stock option exercised by employees	----	----	17.89%257K	4.63%113K	--0	----	----	-54.58%218K	-36.47%108K	--1K
Net other financing activities	---74K	---265K	----	----	----	----	----	27,997.56%11.44M	-48,460.00%-2.43M	--14.15M
Cash from discontinued financing activities
Financing cash flow	-70.71%41K	-400.00%-265K	-66.83%43.46M	505.31%43.38M	-100.00%-5K	162.78%140K	43.01%-53K	85.85%131.05M	-11,248.96%-10.7M	212,135.82%142.06M
Net cash flow
Beginning cash position	-20.59%85.64M	-16.95%141.65M	78.80%170.55M	-33.97%115.31M	90.71%118.53M	48.43%107.85M	78.80%170.55M	-46.13%95.39M	47.35%174.62M	-62.10%62.15M
Current changes in cash	-142.70%-4.56M	10.68%-56M	-138.46%-28.91M	747.97%26.34M	-102.87%-3.22M	201.58%10.68M	-175.89%-62.7M	192.02%75.17M	82.42%-4.07M	347.21%112.47M
End cash Position	-31.59%81.08M	-20.59%85.64M	-16.95%141.65M	-16.95%141.65M	-33.97%115.31M	90.71%118.53M	48.43%107.85M	78.80%170.55M	78.80%170.55M	47.35%174.62M
Free cash flow	-32.53%-29.67M	16.26%-31.1M	11.53%-109.98M	41.43%-18.6M	11.79%-31.86M	14.85%-22.39M	-23.19%-37.14M	-23.34%-124.31M	-36.80%-31.76M	-27.00%-36.12M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall